STRYORA Trademark

Trademark Overview

On Wednesday, August 13, 2014, a trademark application was filed for STRYORA with the United States Patent and Trademark Office. The USPTO has given the STRYORA trademark a serial number of 86365335. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 10, 2021. This trademark is owned by Millennium Pharmaceuticals, Inc.. The STRYORA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
stryora

General Information

Serial Number86365335
Word MarkSTRYORA
Filing DateWednesday, August 13, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 10, 2021
Registration Number4751023
Registration DateTuesday, June 9, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMillennium Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, December 10, 2021CANCELLED SEC. 8 (6-YR)
Monday, July 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 9, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 22, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 9, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 13, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 10, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 9, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 9, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 2, 2015ASSIGNED TO LIE
Friday, January 23, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, December 1, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 1, 2014LETTER OF SUSPENSION E-MAILED
Monday, December 1, 2014SUSPENSION LETTER WRITTEN
Sunday, November 30, 2014ASSIGNED TO EXAMINER
Friday, August 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 16, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

stryora diseases pharmaceutical cancer treatment disorders preparations inflammatory immune malignancies human